Results 231 to 240 of about 3,559,712 (356)
Co-Authorship in Economic History and Economics: Are We Any Different?
Andrew Seltzer, Daniel S. Hamermesh
openalex +1 more source
Gender Disparities in Australian Research Publishing, Citation and Co-Authorship
Hamid R. Jamali, Alireza Abbasi
openalex +1 more source
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero +8 more
wiley +1 more source
Breast cancer publication network: profile of co-authorship and co-organization. [PDF]
Biglu MH, Abotalebi P, Ghavami M.
europepmc +1 more source
The Distribution of Partnerships Benefits: Evidence from Co-Authorships in Economics Journals
Francis Bidault, Thomas Hildebrand
openalex +1 more source
The exegesis and co-authorship: collaboration between supervisors and research students [PDF]
Nigel Krauth +2 more
openalex +1 more source
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source

